KEAP1 and myocardial ischemia: To further clarify whether ginsenoside Rg3 ameliorated ferroptosis induced by myocardial ischemia/reperfusion injury via the keap1/Nrf2 signaling pathway, we used ML334, a keap1/Nrf2 interaction inhibitor.